These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20103625)

  • 21. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
    Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
    Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell cycle-dependent phosphorylation of the RUNX2 transcription factor by cdc2 regulates endothelial cell proliferation.
    Qiao M; Shapiro P; Fosbrink M; Rus H; Kumar R; Passaniti A
    J Biol Chem; 2006 Mar; 281(11):7118-28. PubMed ID: 16407259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
    Duplessis TT; Williams CC; Hill SM; Rowan BG
    Endocrinology; 2011 Jun; 152(6):2517-26. PubMed ID: 21505052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.
    Tian D; Solodin NM; Rajbhandari P; Bjorklund K; Alarid ET; Kreeger PK
    FASEB J; 2015 May; 29(5):2022-31. PubMed ID: 25648997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.
    Mauro L; Pellegrino M; Giordano F; Ricchio E; Rizza P; De Amicis F; Catalano S; Bonofiglio D; Panno ML; Andò S
    FASEB J; 2015 May; 29(5):2150-60. PubMed ID: 25657113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
    Liu W; Ip MM; Podgorsak MB; Das GM
    Breast Cancer Res Treat; 2009 May; 115(1):43-50. PubMed ID: 18481172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNF168 facilitates oestrogen receptor ɑ transcription and drives breast cancer proliferation.
    Liu Z; Zhang J; Xu J; Yang H; Li X; Hou Y; Zhao Y; Xue M; Wang B; Yu N; Yu S; Niu G; Wu G; Li X; Wang H; Zhu J; Zhuang T
    J Cell Mol Med; 2018 Sep; 22(9):4161-4170. PubMed ID: 29974997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the Down-regulation of Estrogen Receptor α.
    Jang SY; Kim J; Hong E; Yang YJ; Na Y; Yeom CH; Park S
    Anticancer Res; 2024 Mar; 44(3):1109-1120. PubMed ID: 38423666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
    Lu W; Katzenellenbogen BS
    Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cells.
    Moy I; Todorović V; Dubash AD; Coon JS; Parker JB; Buranapramest M; Huang CC; Zhao H; Green KJ; Bulun SE
    Oncogene; 2015 Jan; 34(3):323-33. PubMed ID: 24413080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
    Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
    Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
    [No Abstract]   [Full Text] [Related]  

  • 35. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
    Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
    Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
    Nakshatri H; Mendonca MS; Bhat-Nakshatri P; Patel NM; Goulet RJ; Cornetta K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1144-53. PubMed ID: 10772965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
    Giulianelli S; Vaqué JP; Soldati R; Wargon V; Vanzulli SI; Martins R; Zeitlin E; Molinolo AA; Helguero LA; Lamb CA; Gutkind JS; Lanari C
    Cancer Res; 2012 May; 72(9):2416-27. PubMed ID: 22396492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
    Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
    Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
    Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
    Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.